Levosimendan in Acute Heart Failure Following Acute Myocardial Infarction.

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2006
The purpose of this study is to determine the safety and efficacy of a 24 hour infusion with levosimendan in patients with acute myocardial infarction and heart failure after acute percutaneous coronary intervention (PCI) treatment.
Epistemonikos ID: 696f124a19b23b45b13efbc22e4f701e1a9d7332
First added on: May 04, 2024